CMS officially removes one-time restriction for Alzheimer’s PET scan coverage
By
Aaron Dorman
Oct 17, 2023
Seniors covered by Medicare will now have expanded access to Alzheimer’s diagnostic PET scans after the CMS removed one-time restrictions.
AI ‘can’t fly solo,’ needs humanizing context for use in healthcare, data expert emphasizes
By
Aaron Dorman
Oct 10, 2023
A researcher who builds passive AI-enabled monitoring devices believes that if more people adopted tech, it could provide invaluable data.
Key to providing healthcare in senior living? ‘Just get started’
By
Kimberly Bonvissuto
Mar 06, 2023
Thinking about tapping into Medicare payment models to deliver healthcare to senior living residents? One expert has some rather stark advice.
AI model using health records predicts Alzheimer’s disease up to 5 years before diagnosis
By
Kimberly Bonvissuto
Mar 01, 2023
A team of researchers designed an artificial intelligence system that can predict which individuals will develop Alzheimer’s disease up to five years before a diagnosis.
Studies highlight increasing dementia deaths, contributing factors to diagnosis and cognitive decline
By
Kimberly Bonvissuto
Aug 16, 2024
More people are dying from dementia, and location and demographics are among the factors that may contribute to not only a dementia diagnosis, but also to how quickly someone will experience cognitive...
Amyloid probability score 2 has high diagnostic accuracy for Alzheimer’s disease
Jul 31, 2024
The diagnostic accuracy 73% for dementia specialists compared with 91% using the APS2.
New laws increase public awareness, funding for dementia initiatives
By
Kimberly Bonvissuto
Jul 09, 2024
Increasing public awareness of Alzheimer’s and other forms of dementia, along with increasing services for people with diagnoses and their caregivers, are front and center in recent state initiatives...
Dementia with Lewy bodies risk down with α-1 adrenergic receptor antagonists
Jun 19, 2024
The risk for developing dementia with Lewy bodies was lower for men newly started on Tz/Dz/Az compared with those taking tamsulosin or 5ARI.
FDA advisers support new Alzheimer’s drug
Jun 11, 2024
A US Food and Drug Administration advisory panel voted unanimously on Monday to recommend that the benefits of a new drug for Alzheimer’s outweigh its harms, which can include brain swelling and...
Don’t deter ‘necessary capital partners,’ senior living leaders tell federal agencies
By
Kimberly Bonvissuto
Jun 07, 2024
Recent intense focus on the role of private investment in healthcare could create “unintended consequences” that would deter investment in the senior living industry at a time when it can least afford...